Open Access
CC BY 4.0 · Chinese medicine and natural products 2022; 02(01): e44-e54
DOI: 10.1055/s-0042-1747917
Original Article

Mechanism of Olibanum and Myrrha for the Acute Soft Tissue Injury Based on Network Pharmacology

Miao Tan
1   The First Clinical Medical College, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China
,
Yan Cheng
2   Outpatient Office, Shaanxi Province Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, China
› Institutsangaben

Funding This work was supported by the Science and Technology Project of Xi 'an Science and Technology Bureau [201805093YX1SF27(16)] and Scientific Research Project of Shaanxi Provincial Administration of Traditional Chinese Medicine (15-JC014).
Preview

Abstract

Objective The objective of this study was to screen the therapeutic target of olibanum and myrrha on acute soft tissue injury (ASTI) by network pharmacology and to clarify their mechanisms.

Methods The main chemical constituents and the targets of olibanum and myrrha were obtained by using traditional Chinese medicine systems pharmacology database and analysis platform database. The disease targets of ASTI were searched by GeneCards. The intersection targets of herbs and diseases were selected for protein interaction analysis, protein–protein interaction network was constructed, and potential protein functional modules in the network were explored. A compound–target–disease network was constructed using Cytoscape3.8.2 software. The targets were analyzed by gene ontology analysis and Kyoto Encyclopedia of Genes and Genomes enrichment analysis based on the Metascape database.

Results The core active components of olibanum and myrrha were quercetin, β-sitosterol, and stigmasterol. The core targets were PGR, NCOA2, PTGS2, PRKCA, and NR3C2. Pathways in cancer, AGE-RAGE signaling pathway in diabetic complications might play a potential role in olibanum and myrrha in the treatment of ASTI.

Conclusion Olibanum and myrrha have the characteristics of multiple components, multiple targets, and overall regulation in the treatment of ASTI.

Credit Autorship Contribution Statement

Miao Tan: Data collection and curation, formal analysis, software, and writing original draft. Yan Cheng: Conceptualization, methodology, supervision, and writing - review & editing.




Publikationsverlauf

Eingereicht: 08. Januar 2021

Angenommen: 23. Februar 2022

Artikel online veröffentlicht:
07. Juli 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany